Decoy Therapeutics Gross Profit Growth & History (DCOY)
Decoy Therapeutics's gross profit was $1.5M for fiscal 2018.
View full Decoy Therapeutics company overviewDecoy Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2018 | 2018-12-31 | $1.5M | $752,632 | +98.00% |
| 2017 | 2017-12-31 | $767,969 | $420,053 | +120.73% |
| 2016 | 2016-12-31 | $347,916 | $347,916 | — |
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | — | — |
Decoy Therapeutics quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2019 | 2019-06-30 | $859,630 | $794,073 | +1211.27% |
| Q1 2019 | 2019-03-31 | $608,306 | $513,658 | +542.70% |
| Q4 2018 | 2018-12-31 | $88,133 | −$61,352 | −41.04% |
| Q3 2018 | 2018-09-30 | $377,114 | $112,269 | +42.39% |
| Q2 2018 | 2018-06-30 | $65,557 | −$124,641 | −65.53% |
| Q1 2018 | 2018-03-31 | $94,648 | −$68,793 | −42.09% |
| Q4 2017 | 2017-12-31 | $149,485 | −$15,713 | −9.51% |
| Q3 2017 | 2017-09-30 | $264,845 | −$113,139 | −29.93% |
| Q2 2017 | 2017-06-30 | $190,198 | $188,444 | +10743.67% |
| Q1 2017 | 2017-03-31 | $163,441 | $360,461 | — |
| Q4 2016 | 2016-12-31 | $165,198 | — | — |
| Q3 2016 | 2016-09-30 | $377,984 | $377,984 | — |
| Q2 2016 | 2016-06-30 | $1,754 | $1,754 | — |
| Q1 2016 | 2016-03-31 | −$197,020 | — | — |
| Q3 2015 | 2015-09-30 | $0 | — | — |
| Q2 2015 | 2015-06-30 | $0 | — | — |
Decoy Therapeutics gross profit trends
Between the periods ended 2014-12-31 and 2018-12-31, Decoy Therapeutics's gross profit increased from $0 to $1.5M, a change of $1.5M. The latest reported quarter, Q2 2019, shows $859,630.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Decoy Therapeutics source filings ↗